Triglide Articles
Tokyo pharma stocks - week to April 8
15 April 2002
Chinese firms looking at PT Indofarma
8 April 2002
IMPAX gets initial OK for generic Tricor
4 March 2002
Abbott posts strong revenue growth for 2001, but charges hit
21 January 2002
Call for Indonesian drug pricing panel
28 November 2001
Abbott sales up 26% though earnings slip
11 October 2001
Abbott sales up 26% though earnings slip
10 October 2001
Greek deaths linked to cholesterol-lowerers
28 August 2001
Canadian product news in brief
7 August 2001
Abbott sales growth driven by pharma
13 July 2001
Bayer pulls higher dose of Lipobay in UK
5 July 2001
US pharma business driving Abbott
17 April 2001
US pharma business driving Abbott
12 April 2001
OEB revokes license of Fournier's lead drug
21 December 1999
Fournier entry into Japan approved
8 April 1999
Abbott 1998 sales reach $12.5 billion
18 January 1999
Indonesia's retail price of health care
13 October 1998
Indonesia Cuts Generics Prices 20%
24 August 1998
Abbott Labs Impacted By Strength Of Dollar
14 July 1998
Fournier Makes Swedish Acquisition
15 June 1998
Indonesia Drug Prices
8 May 1998
Fournier's Sales Advance 10.3%
7 May 1998
Pharma Pollution Found In European Water
1 April 1998
France's Fournier Gets Ready To Blossom
12 March 1998
FDA Clears Abbott/Fournier's Tricor
13 February 1998
Abbott To Market Fournier's Fenofibrate
14 January 1998
Fournier To Copromote Baycol In Canada
13 January 1998
Thylmer Created By Fournier In Canada
10 July 1997
Lipobay Selected For Large UK Study In Diabetics
24 June 1997
Fournier's Sales Advance 8.2% In 1996
12 May 1997
First Launch Of Parke-Davis' Lipitor
10 February 1997
Fournier Fights Back Over Generics Case
27 January 1997
Fournier Loses Appeal Over Generics
4 November 1996
Fournier Wins Lipanthyl Case
30 September 1996
Fournier Ready For Generics Battle With Merck
1 April 1996
Merck & Co Moves Into French Generics Battle
19 February 1996
Fournier Will Remain Independent Company
23 October 1995
Fournier holds back on Lipidil
22 May 1995
Kissei Sales Better Than Expected
3 October 1994
Grelan And Kaken Comarketing Agreement
3 October 1994
Fournier, Allelix in R&D Link-Up
15 August 1994
GIST-BROCADES BIDS FOR PIERREL UNIT
23 May 1994
INDONESIA EXEMPTS DRUG INDUSTRY
28 March 1994
FOURNIER TALKS WITH PHARMACIA ON PIERREL
17 January 1994
FDA YEAR-END APPROVALS FOR 1993
10 January 1994
FOURNIER MAKES MOVE ON INTERNATIONAL STAGE
6 December 1993
FLURBIPROFEN AND CONVULSIONS
5 July 1993
ORION, GRELAN IN ANTIULCERANT DEAL
8 March 1993
FOURNIER IN R&D DEAL WITH GRELAN
1 February 1993
HYPOLIPIDEMICS INFO
23 March 1992
FAMILY PLANNING in INDONESIA
27 January 1992
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
